Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Alder II in conjunction with the acquisition of Scanacon
Mandate

Vinge advises Alder II in conjunction with the acquisition of Scanacon

September 26, 2018 M&A

Alder II has entered into an agreement together with the management of the company to acquire the entire issued share capital of Scanacon Intressenter from the seller Verdane Capital.

Scanacon will be the first investment in Alder’s new fund, i.e. Alder II. Alder II is a Swedish based investment fund which invests in Nordic sustainable technology companies. The investments focus on established companies in the Nordic region.

Vinge’s team consisted of, among others, Johan Larsson, Albert Wållgren, Filip Brosset, Manne Bergström, Stina Bengtsson, Ludvig Wettergren and Andreas Lexhag which represented the purchaser Alder II in connection with the acquisition.  

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025